HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 604 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $193,318 | +12.3% | 1,671 | -0.1% | 0.02% | +22.2% |
| Q2 2023 | $172,068 | -7.3% | 1,673 | -1.6% | 0.02% | -18.2% |
| Q1 2023 | $185,538 | -76.1% | 1,700 | -75.0% | 0.02% | -76.8% |
| Q4 2022 | $775,319 | +85.9% | 6,813 | +1.0% | 0.10% | +35.7% |
| Q3 2022 | $417,000 | -23.1% | 6,743 | -0.9% | 0.07% | -22.2% |
| Q2 2022 | $542,000 | -24.2% | 6,801 | +0.1% | 0.09% | -18.2% |
| Q1 2022 | $715,000 | -2.5% | 6,793 | -0.1% | 0.11% | -1.8% |
| Q4 2021 | $733,000 | +578.7% | 6,799 | +588.2% | 0.11% | +300.0% |
| Q3 2021 | $108,000 | +52.1% | 988 | +29.7% | 0.03% | +75.0% |
| Q2 2021 | $71,000 | -20.2% | 762 | -20.8% | 0.02% | -20.0% |
| Q1 2021 | $89,000 | -19.8% | 962 | -36.5% | 0.02% | -25.9% |
| Q4 2020 | $111,000 | +46.1% | 1,516 | +54.7% | 0.03% | +28.6% |
| Q3 2020 | $76,000 | +660.0% | 980 | +469.8% | 0.02% | +600.0% |
| Q2 2020 | $10,000 | +66.7% | 172 | -16.5% | 0.00% | +50.0% |
| Q1 2020 | $6,000 | -83.3% | 206 | -79.4% | 0.00% | -84.6% |
| Q4 2019 | $36,000 | +33.3% | 1,000 | 0.0% | 0.01% | +30.0% |
| Q3 2019 | $27,000 | +12.5% | 1,000 | 0.0% | 0.01% | +11.1% |
| Q2 2019 | $24,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |